Related references
Note: Only part of the references are listed.Biosimilars for Retinal Diseases: An Update
Ashish Sharma et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
Clinical efficacy and safety of Razumab® (CESAR) study: Our experience with the world's first biosimilar Ranibizumab
Lalit Verma et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2021)
PHARMACOKINETIC STUDY OF INTRAVITREAL AFLIBERCEPT IN HUMANS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Diana V. Do et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2020)
One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study
Enrico Borrelli et al.
ACTA DIABETOLOGICA (2020)
A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema The European DME Registry Study
Amir Rosenblatt et al.
OPHTHALMOLOGY (2020)
Association of the Somatostatin Analog Octreotide With Magnetic Nanoparticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic Retinopathy
Rosario Amato et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Safety and Biocompatibility of Aflibercept-Loaded Microsphere Thermo-Responsive Hydrogel Drug Delivery System in a Nonhuman Primate Model
Soohyun Kim et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2020)
Intraocular Distribution and Kinetics of Intravitreally Injected Antibodies and Nanoparticles in Rabbit Eyes
Hyeong Min Kim et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2020)
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
Ruben Varela-Fernandez et al.
PHARMACEUTICS (2020)
被撤回的出版物: Sustained delivery of epalrestat to the retina using PEGylated solid lipid nanoparticles laden contact lens (Retracted article. See vol. 624, 2022)
Yanni Zhu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Intravitreal hydrogels for sustained release of therapeutic proteins
Blessing C. Ilochonwu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
Javier Zarranz-Ventura et al.
CLINICAL OPHTHALMOLOGY (2020)
A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes
Raquel Estebainha et al.
CURRENT OPHTHALMOLOGY REPORTS (2020)
Characterization of Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Ranibizumab
Wenqiang Liu et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2019)
Highly bioactive, bevacizumab-loaded, sustained-release PLGA/PCADK microspheres for intravitreal therapy in ocular diseases
Jiaxin Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration Results from the Randomized Phase 2 Ladder Clinical Trial
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2019)
Association between ICAM-1 level and diabetic retinopathy: a review and meta-analysis
Yang Yao et al.
POSTGRADUATE MEDICAL JOURNAL (2019)
Thermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits
Chao-Chien Hu et al.
TECHNOLOGY AND HEALTH CARE (2019)
Challenges and opportunities for drug delivery to the posterior of the eye
Fernando J. Cabrera et al.
DRUG DISCOVERY TODAY (2019)
Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats
Yi Dong et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2019)
Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro
Wenqiang Liu et al.
CURRENT EYE RESEARCH (2019)
Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial
Rafael Simo et al.
DIABETES (2019)
Neuroprotective effect of insulin-loaded chitosan nanoparticles/PLGA-PEG-PLGA hydrogel on diabetic retinopathy in rats
Xianfang Rong et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy
Eugene Yu-Chuan Kang et al.
JAMA OPHTHALMOLOGY (2019)
Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy
Joonas Wirkkala et al.
BMJ OPEN OPHTHALMOLOGY (2019)
Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the 'DR-Pro-DEX Study'
Matias Iglicki et al.
ACTA DIABETOLOGICA (2018)
Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: Current status and challenges
Chi Ming Laurence Lau et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy
Rosario Amato et al.
CURRENT NEUROPHARMACOLOGY (2018)
Diabetic Retinopathy: Pathophysiology and Treatments
Wei Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cell penetrating peptides in ocular drug delivery: State of the art
S. Pescina et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Effect of nanoencapsulation using poly (lactide-co-glycolide) (PLGA) on anti-angiogenic activity of bevacizumab for ocular angiogenesis therapy
Xiao-Pei Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration
Patricia Bogdanov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
Jay S. Skyler et al.
DIABETES (2017)
Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation
Jayamanti Pandit et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2017)
Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes
Magdalena Edington et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Sobha Sivaprasad et al.
LANCET (2017)
Pharmacokinetic aspects of retinal drug delivery
Eva M. del Amo et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2017)
The pathology associated with diabetic retinopathy
Judith Lechner et al.
VISION RESEARCH (2017)
Change in Diabetic Retinopathy Through 2 Years Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab
Susan B. Bressler et al.
JAMA OPHTHALMOLOGY (2017)
Systemic Biodistribution and Intravitreal Pharmacokinetic Properties of Bevacizumab, Ranibizumab, and Aflibercept in a Nonhuman Primate Model
John Byron Christoforidis et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Ischemic index changes in diabetic retinopathy after intravitreal dexamethasone implant using ultra-widefield fluorescein angiography: a pilot study
Lea Querques et al.
ACTA DIABETOLOGICA (2017)
Topical Delivery of Anti-VEGF Drugs to the Ocular Posterior Segment Using Cell-Penetrating Peptides
Felicity de Cogan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy
Yoo-Ri Chung et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Efficacy and safety of topical difluprednate in persistent diabetic macular edema
Savleen Kaur et al.
INTERNATIONAL OPHTHALMOLOGY (2016)
Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review
Daniel Shu Wei Ting et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2016)
Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage
Ji Hoon Jeong et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Dexamethasone - PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation
Burcin Yavuz et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab
Naba Elsaid et al.
MOLECULAR PHARMACEUTICS (2016)
Intravitreal Aflibercept for Diabetic Macular Edema 148-Week Results from the VISTA and VIVID Studies
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
John A. Wells et al.
OPHTHALMOLOGY (2016)
Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat
Marialaura Amadio et al.
PHARMACOLOGICAL RESEARCH (2016)
The progress in understanding and treatment of diabetic retinopathy
Alan W. Stitt et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2016)
Small molecule therapeutic-loaded liposomes as therapeutic carriers: from development to clinical applications
Jae Yoon Hwang et al.
RSC ADVANCES (2016)
Intraocular Pharmacokinetics of Intravitreal Aflibercept (Eylea) in a Rabbit Model
Sang Jun Park et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Topical dexamethasone -cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema
Akihiro Ohira et al.
ACTA OPHTHALMOLOGICA (2015)
The suprachoroidal pathways: a new drug delivery route to the back of the eye
Uma Do J. P. Rai et al.
DRUG DISCOVERY TODAY (2015)
Current nanotechnology approaches for the treatment and management of diabetic retinopathy
Joana F. Fangueiro et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
The role of CTGF in diabetic retinopathy
Ingeborg Klaassen et al.
EXPERIMENTAL EYE RESEARCH (2015)
An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease
Binbin Xie et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy A Randomized Clinical Trial
Jeffrey G. Gross et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment
Reyhaneh Varshochian et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2015)
In Vitro/In Vivo Evaluation of DexamethasonePAMAM Dendrimer Complexes for Retinal Drug Delivery
Burcin Yavuz et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Long-term Effects of Therapy with Ranibizumab on Diabetic Retinopathy Severity and Baseline Risk Factors for Worsening Retinopathy
Michael S. Ip et al.
OPHTHALMOLOGY (2015)
Injectable Chemically Crosslinked Hydrogel for the Controlled Release of Bevacizumab in Vitreous: A 6-Month In Vivo Study
Yu Yu et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2015)
Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema
Rodolfo Mastropasqua et al.
PLOS ONE (2015)
A Novel Technique for Repositioning of a Migrated ILUVIEN® (Fluocinolone Acetonide) Implant into the Anterior Chamber
Ibraheem A. El-Ghrably et al.
OPHTHALMOLOGY AND THERAPY (2015)
Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes
Yuichi Niwa et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina
Siva P. Kambhampati et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment
Raimo Tuuminen et al.
ACTA OPHTHALMOLOGICA (2014)
Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy
Rafael Simo et al.
DIABETES CARE (2014)
Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year results
K. Kriechbaum et al.
EYE (2014)
Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes
Elad Moisseiev et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
Intravitreal Injection of Ranibizumab and CTGF shRNA Improves Retinal Gene Expression and Microvessel Ultrastructure in a Rodent Model of Diabetes
Bojie Hu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Advanced Glycation End Products and Diabetic Complications
Varun Parkash Singh et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2014)
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
David S. Boyer et al.
OPHTHALMOLOGY (2014)
Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-associated Liposomes
Benjamin M. Davis et al.
SMALL (2014)
Side-Effects and Complications of Laser Treatment in Diabetic Retinal Disease
Emily K. Deschler et al.
SEMINARS IN OPHTHALMOLOGY (2014)
Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets
Sher Zaman Safi et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema
Mark Humayun et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2014)
Biocompatible Reverse Thermal Gel Sustains the Release of Intravitreal Bevacizumab In Vivo
Britta M. Rauck et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Targeted Intraceptor Nanoparticle Therapy Reduces Angiogenesis and Fibrosis in Primate and Murine Macular Degeneration
Ling Luo et al.
ACS NANO (2013)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Topical Administration of Somatostatin Prevents Retinal Neurodegeneration in Experimental Diabetes
Cristina Hernandez et al.
DIABETES (2013)
The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments
Reyhaneh Varshochian et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
A Preliminary Evaluation of Dexamethasone Palmitate Emulsion: A Novel Intravitreal Sustained Delivery of Corticosteroid for Treatment of Macular Edema
Philippe Daull et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Pharmacokinetics of Intravitreally Injected Bevacizumab in Vitrectomized Eyes
Jeeyun Ahn et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Light-Activated, In Situ Forming Gel for Sustained Suprachoroidal Delivery of Bevacizumab
Puneet Tyagi et al.
MOLECULAR PHARMACEUTICS (2013)
Aqueous Levels of Fluocinolone Acetonide after Administration of Fluocinolone Acetonide Inserts or Fluocinolone Acetonide Implants
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2013)
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials RISE and RIDE
David M. Brown et al.
OPHTHALMOLOGY (2013)
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
Uday B. Kompella et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2013)
ANATOMIC AND PHARMACOKINETIC PROPERTIES OF INTRAVITREAL BEVACIZUMAB AND RANIBIZUMAB AFTER VITRECTOMY AND LENSECTOMY
John B. Christoforidis et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Current treatments in diabetic macular oedema: systematic review and meta-analysis
John Alexander Ford et al.
BMJ OPEN (2013)
Pharmacokinetics of Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration: A Population Approach
Lu Xu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Preliminary results of an intravitreal dexamethasone implant (Ozurdex (R)) in patients with persistent diabetic macular edema
Elena Pacella et al.
CLINICAL OPHTHALMOLOGY (2013)
The Effect of the Oral PKC β Inhibitor Ruboxistaurin on Vision Loss in Two Phase 3 Studies
Matthew J. Sheetz et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Treatment of diffuse diabetic macular oedema using steroid eye drops
Sakiko Nakano Goto et al.
ACTA OPHTHALMOLOGICA (2012)
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
Nicholas Papadopoulos et al.
ANGIOGENESIS (2012)
Long-term Effects of Ranibizumab on Diabetic Retinopathy Severity and Progression
Michael S. Ip et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Extended Release of Bevacizumab by Thermosensitive Biodegradable and Biocompatible Hydrogel
Chau-Hui Wang et al.
BIOMACROMOLECULES (2012)
A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy
Rob J. Van Geest et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Corticosteroid Use for Diabetic Macular Edema: Old Fad or New Trend?
Michael W. Stewart
CURRENT DIABETES REPORTS (2012)
Intravitreal Versus Subtenon Triamcinolone Acetonide Injection for Diabetic Macular Edema: A Systematic Review and Meta-analysis
Hui-Ping Qi et al.
CURRENT EYE RESEARCH (2012)
Pharmacokinetic Properties of Intravitreal I-124-Aflibercept in a Rabbit Model Using PET/CT
John B. Christoforidis et al.
CURRENT EYE RESEARCH (2012)
Incidence and Progression of Diabetic Retinopathy During 17 Years of a Population-Based Screening Program in England
Colin D. Jones et al.
DIABETES CARE (2012)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W. Y. Yau et al.
DIABETES CARE (2012)
Liposomes for intravitreal drug delivery: A state of the art
Amelie Bochot et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Pigment Epithelium-Derived Factor (PEDF) Peptide Eye Drops Reduce Inflammation, Cell Death and Vascular Leakage in Diabetic Retinopathy in Ins2Akita Mice
Yanling Liu et al.
MOLECULAR MEDICINE (2012)
Osteopontin and Other Regulators of Angiogenesis and Fibrogenesis in the Vitreous from Patients with Proliferative Vitreoretinal Disorders
Ahmed M. Abu El-Asrar et al.
MEDIATORS OF INFLAMMATION (2012)
Safety of Submacular Suprachoroidal Drug Administration via a Microcatheter: Retrospective Analysis of European Treatment Results
Manfred Tetz et al.
OPHTHALMOLOGICA (2012)
Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2012)
Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease
Joanna Kur et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2012)
The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation
Jin Hyoung Kim et al.
BIOMATERIALS (2011)
Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye
Joana Araujo et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2011)
Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye
J. J. Chen et al.
EYE (2011)
Sustained-Release Intravitreal Liquid Drug Delivery Using Triamcinolone Acetonide for Cystoid Macular Edema in Retinal Vein Occlusion
Jennifer I. Lim et al.
OPHTHALMOLOGY (2011)
Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical Trial
P. Andrew Pearson et al.
OPHTHALMOLOGY (2011)
ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN Efficacy, Safety, and Causes of Vision Loss Among 813 Patients (1,392 Eyes) with Diabetic Retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein kinase C β Inhibitor-Diabetic Retinopathy Study 2
Lloyd Paul Aiello et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant
Joan-En Chang-Lin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Pharmacokinetics of intravitreal bevacizumab (Avastin (R)) in rabbits
Christos I. Sinapis et al.
CLINICAL OPHTHALMOLOGY (2011)
Corneal Penetration of Topical and Subconjunctival Bevacizumab
Mohammad H. Dastjerdi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Topical Dexamethasone-Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema
Masaki Tanito et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
PET/CT Imaging of I-124-Radiolabeled Bevacizumab and Ranibizumab after Intravitreal Injection in a Rabbit Model
John B. Christoforidis et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Pedro Geraldes et al.
CIRCULATION RESEARCH (2010)
Surgical management of the late complications of proliferative diabetic retinopathy
D. K. Newman
EYE (2010)
Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema
Sakiko Nakano et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications
J. Araujo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Cell-penetrating peptide TAT-mediated delivery of acidic FGF to retina and protection against ischemia-reperfusion injury in rats
Yi Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.
Emily Y. Chew et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sustained Ocular Delivery of Fluocinolone Acetonide by an Intravitreal Insert
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2010)
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Michael J. Elman et al.
OPHTHALMOLOGY (2010)
A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study) 12-Month Data: Report 2
Michel Michaelides et al.
OPHTHALMOLOGY (2010)
Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin
Leslie N. Johnson et al.
VISION RESEARCH (2010)
Recent advances in ophthalmic drug delivery
Uday B. Kompella et al.
THERAPEUTIC DELIVERY (2010)
Rapid and persistent regression of severe new vessels on the disc in proliferative diabetic retinopathy after a single intravitreal injection of pegaptanib
Efstratios Mendrinos et al.
ACTA OPHTHALMOLOGICA (2009)
Three-Year Follow-up of a Randomized Trial Comparing Focal/Grid Photocoagulation and Intravitreal Triamcinolone for Diabetic Macular Edema
ARCHIVES OF OPHTHALMOLOGY (2009)
Protective Effect of Perindopril on Diabetic Retinopathy Is Associated With Decreased Vascular Endothelial Growth Factor-to-Pigment Epithelium-Derived Factor Ratio Involvement of a Mitochondria-Reactive Oxygen Species Pathway
Zhi Zheng et al.
DIABETES (2009)
Nanoparticle-Mediated Expression of an Angiogenic Inhibitor Ameliorates Ischemia-Induced Retinal Neovascularization and Diabetes-Induced Retinal Vascular Leakage
Kyoungmin Park et al.
DIABETES (2009)
Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progression of tractional retinal detachment
R. Krishnan et al.
EYE (2009)
Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes.
Michael Mauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Mark C. Gillies et al.
OPHTHALMOLOGY (2009)
PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION
Majid Abrishami et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
HMG-CoA Reductase Inhibitors (Statin) Prevents Retinal Neovascularization in a Model of Oxygen-Induced Retinopathy
Manuela Bartoli et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Pharmacokinetics of Bevacizumab after Topical, Subconjunctival, and Intravitreal Administration in Rabbits
Hiroyuki Nomoto et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Posterior Juxtascleral Infusion of Modified Triamcinolone Acetonide Formulation for Refractory Diabetic Macular Edema: One-Year Follow-Up
Daniele Veritti et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up
J. F. Arevalo et al.
EYE (2009)
Treatment of posterior uveitis with a fluocinolone acetonide implant - Three-year clinical trial results
David G. Callanan et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins
Shuhei Kawahara et al.
DIABETES (2008)
Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: A randomized double-masked clinical trial
A. Mirshahi et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2008)
Short-term complications of intravitreal injections of triamcinolone and bevacizumab
J. B. Jonas et al.
EYE (2008)
Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy
Siamak Moradian et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
Nish Chaturvedi et al.
LANCET (2008)
Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea
Leslie N. Johnson et al.
MOLECULAR THERAPY (2008)
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema
Michael S. Ip et al.
OPHTHALMOLOGY (2008)
Vitreous levels of bevackumab and vascular endothelial growth factor-A in patients with choroidal neovascularization
Qi Zhu et al.
OPHTHALMOLOGY (2008)
The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
Esther J. Kuiper et al.
PLOS ONE (2008)
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy
J. F. Arevalo et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Pharmacokinetics of intravitreal ranibizumab (Lucentis)
Sophie J. Bakri et al.
OPHTHALMOLOGY (2007)
Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina
Esther J. Kuiper et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Management of diabetic retinopathy - A systematic review
Quresh Mohamed et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Novel approaches to retinal drug delivery
Kumar G. Janoria et al.
EXPERT OPINION ON DRUG DELIVERY (2007)
Magnetic nanoparticles for drug delivery
Manuel Arruebo et al.
NANO TODAY (2007)
Pharmacokinetics of intravitreal bevackumab (avastin)
Sophie J. Bakri et al.
OPHTHALMOLOGY (2007)
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema
Baruch D. Kuppermann et al.
ARCHIVES OF OPHTHALMOLOGY (2007)
Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology
Timothy S. Kern et al.
DIABETES (2007)
Arteriolar involvement in the microvascular lesions of diabetic retinopathy: Implications for pathogenesis
Tom A. Gardiner et al.
MICROCIRCULATION (2007)
Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization
Jose M. Ruiz-Moreno et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2006)
Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy
Prema Abraham et al.
OPHTHALMOLOGY (2006)
Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy
John O. Mason et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye
Esther J. Kuiper et al.
ARCHIVES OF OPHTHALMOLOGY (2006)
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
Robert L. Avery et al.
OPHTHALMOLOGY (2006)
Intravitreal triamcinolone for refractory diabetic macular edema - Two-year results of a double-masked, placebo-controlled, randomized clinical trial
Mark C. Gillies et al.
OPHTHALMOLOGY (2006)
Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy
MG Krzystolik et al.
ARCHIVES OF OPHTHALMOLOGY (2006)
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis - Thirty-four-week results of a multicenter randomized clinical study
GJ Jaffe et al.
OPHTHALMOLOGY (2006)
Chitosan nanoparticles as a potential drug delivery system for the ocular surface:: Toxicity, uptake mechanism and in vivo tolerance
AE de Salamanca et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage
Richard F. Spaide et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Hexosamines, insulin resistance, and the complications of diabetes: current status
MG Buse
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
PKD at the crossroads of DAG and PKC signaling
Qiming J. Wang
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Topical and systemic drug delivery to the posterior segments
PM Hughes et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications
IG Obrosova
ANTIOXIDANTS & REDOX SIGNALING (2005)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: A randomized clinical trial
MA Bonini et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Topically applied antibody fragments penetrate into the back of the rabbit eye
KA Williams et al.
EYE (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina
H Tamura et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy
DR Hinton et al.
DIABETES CARE (2004)
Connective tissue growth factor is up-regulated in the diabetic retina: Amelioration by angiotensin-converting enzyme inhibition
C Tikellis et al.
ENDOCRINOLOGY (2004)
Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy
Z Dagher et al.
DIABETES (2004)
Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema
F Audren et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes
S Miyahara et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin
S Sarlos et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Diabetic retinopathy and diabetic macular edema - Pathophysiology, screening, and novel therapies
TA Ciulla et al.
DIABETES CARE (2003)
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection
PM Beer et al.
OPHTHALMOLOGY (2003)
Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression
UB Kompella et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes - Transgenic and interventional studies
CJ Moravski et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Intraocular pressure after intravitreal injection of triamcinolone acetonide
JB Jonas et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
Statins have biphasic effects on angiogenesis
M Weis et al.
CIRCULATION (2002)
Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy
IMH van Buggenum et al.
DIABETOLOGIA (2002)
Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy
H Funatsu et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis
I Inoki et al.
FASEB JOURNAL (2001)
Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons
M Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy
BO Boehm et al.
HORMONE AND METABOLIC RESEARCH (2001)
Effect of particle size of polymeric nanospheres on intravitreal kinetics
E Sakurai et al.
OPHTHALMIC RESEARCH (2001)
Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys
DW Drolet et al.
PHARMACEUTICAL RESEARCH (2000)
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes
RE Gilbert et al.
DIABETOLOGIA (2000)
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
XL Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)
The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy - A randomized controlled study
MB Grant et al.
DIABETES CARE (2000)
Share Paper
